Squarepoint Ops »

Candel Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-06-30 $76k 12k 6.20

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Msci Brazil Etf Call Option (EWZ)
Tesla Motors Call Option (TSLA)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for Squarepoint Ops

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Sands Capital Ventures
Nuveen Asset Management
Susquehanna International
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Jane Street
HB Wealth Management
Charles Schwab Investment Management

View all funds holding Candel Therapeutics